Novo Nordisk Acquires Emisphere’s Eligen® Technology for US$1.8 B

By Michelle Liu

Pharma Deals Review: Vol 2020 Issue 11 (Table of Contents)

Published: 19 Nov-2020

DOI: 10.3833/pdr.v2020.i11.2570     ISSN: 1756-7874

Section: Mergers & Acquisitions



In its second largest M&A deal to date, Novo Nordisk has agreed to acquire Emisphere Technologies, a drug delivery company focused on the development of oral formulations of therapeutics using its Eligen® technology, for US$1...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details